Cochrane · systematic review · CD000204

Anticholinergic medication for antipsychotic‐induced tardive dyskinesia

Bergman, H, Soares‐Weiser, K · Cochrane Database of Systematic Reviews · 2018 · Cochrane Library

SchizophreniaAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
18
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 14 · 77.8%Very low 4 · 22.2%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Anticholinergic medication compared with placebo for antipsychotic‐induced tardive dyskinesia

Population: patients with antipsychotic‐induced tardive dyskinesia
6 questions
OutcomeEffectEvidenceStatus / GRADE
Tardive dyskinesia: not improved to a clinically important extent
Anticholinergic medication vs placebo
no estimate extracted0 studies · 0 participantsUngraded
Tardive dyskinesia: deterioration of symptoms
Anticholinergic medication vs placebo
no estimate extracted0 studies · 0 participantsUngraded
Mental state
Anticholinergic medication vs placebo
no estimate extracted0 studies · 0 participantsUngraded
Adverse effect: any adverse effects
Anticholinergic medication vs placebo
no estimate extracted0 studies · 0 participantsUngraded
Acceptability of the treatment: leaving the study early
Anticholinergic medication vs placebo
no estimate extracted0 studies · 0 participantsUngraded
Social confidence, social inclusion, social networks, or personalised quality of life
Anticholinergic medication vs placebo
no estimate extracted0 studies · 0 participantsUngraded

Anticholinergic medication compared with other treatments for antipsychotic‐induced tardive dyskinesia

Population: chronic schizophrenia patients with antipsychotic‐induced tardive dyskinesia
6 questions
OutcomeEffectEvidenceStatus / GRADE
Tardive dyskinesia: Not improved to a clinically important extent
Anticholinergic medication vs other treatments
RR 4.2 [1.4, 12.58]1 study · 20 participantsVery low
Downgraded: risk of bias
Tardive dyskinesia: deterioration of symptoms
Anticholinergic medication vs other treatments
no estimate extracted0 studies · 0 participantsUngraded
Mental state
Anticholinergic medication vs other treatments
no estimate extracted0 studies · 0 participantsUngraded
Adverse effect: any adverse effects
Anticholinergic medication vs other treatments
RR 0.33 [0.02, 7.32]1 study · 20 participantsVery low
Downgraded: risk of bias
Acceptability of the treatment: leaving the study early
Anticholinergic medication vs other treatments
RR 0.33 [0.02, 7.32]1 study · 20 participantsVery low
Downgraded: risk of bias
Social confidence, social inclusion, social networks, or personalised quality of life
Anticholinergic medication vs other treatments
no estimate extracted0 studies · 0 participantsUngraded

Withdrawal of anticholinergic medication compared to continuing anticholinergic medication for antipsychotic‐induced tardive dyskinesia

Population: chronic schizophrenia patients with antipsychotic‐induced tardive dyskinesia
6 questions
OutcomeEffectEvidenceStatus / GRADE
Tardive dyskinesia: not improved to a clinically important extent
Withdrawal of anticholinergic medication vs continuing anticholinergic medication
no estimate extracted0 studies · 0 participantsUngraded
Tardive dyskinesia: deterioration of symptoms
Withdrawal of anticholinergic medication vs continuing anticholinergic medication
no estimate extracted0 studies · 0 participantsUngraded
Mental state
Withdrawal of anticholinergic medication vs continuing anticholinergic medication
no estimate extracted0 studies · 0 participantsUngraded
Adverse effects
Withdrawal of anticholinergic medication vs continuing anticholinergic medication
no estimate extracted0 studies · 0 participantsUngraded
Acceptability of the treatment: leaving the study early
Withdrawal of anticholinergic medication vs continuing anticholinergic medication
RR 2.14 [0.11, 42.52]1 study · 10 participantsVery low
Downgraded: risk of bias
Social confidence, social inclusion, social networks, or personalised quality of life
Withdrawal of anticholinergic medication vs continuing anticholinergic medication
no estimate extracted0 studies · 0 participantsUngraded